-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - Every 15 days until end of study period Asymptomatic
Total: 18* (8.9)*
HIV-: 12 (6.5)
HIV+: 6 (33.3) … Hypertension: 14* (26.4)
Diabetes:6* (9.4)
Liver disease: 0 (0)
CVD: 4* (7.5)
Asthma:4* (5.7)
CKD stage … Nonseroconverter: 22 (66.7)
Seroconverter: 59 (59.6) Diabetes: 29 (22)
Respiratory disease: 18 (13.6)
Renal … the week where they reported having received their first dose of any SARS-CoV-2 vaccine or up to the end … after baseline (for unvaccinated individuals and individuals with one-dose hybrid immunity), death, or end
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
October 01, 2014 - the study questions, the EPC consulted a panel of Key Informants who represent
subject experts and end-users … Therefore, in the end, study questions, design, methodological
approaches and/or conclusions do not … Because of their role as end-users,
individuals with potential conflicts may be retained. … Axillary lymph node dissection in early-
stage invasive breast cancer: is it still standard today? … magnetic resonance imaging
changes after sorafenib and sunitinib chemotherapy in patients with advanced
renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
February 01, 2008 - There is usually a postictal phase with
confusion that accompanies the end of convulsions. … Partial Neurological: sedation,
dizziness, confusion,
headache, psychosis
Non-Neurological:
Anorexia, renal … , generalized, specific epilepsy syndrome), seizure type (new onset, chronic
disease), severity or stage … of illness
Severity or stage of illness
(referral or primary care
population)
Population Events … $ at the end of a term indicates that this term has been truncated.
?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
November 24, 2014 - More information regarding patients’ baseline characteristics,
particularly renal clearance, APACHE … results section, we have added more details when
available on baseline characteristics, particularly renal … realize that there was an opportunity for
public comments on the study design, and that this was
the stage … In the Results section we added data on baseline
characteristics, particularly renal clearance, APACHE … ,
or antibiotic-related adverse events differ for subgroups
defined by age, sex, race, ethnicity, renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/search-strategy-white-paper.pdf
February 01, 2025 - Individual reviewed tools can be used at more than one stage. … have attempted to provide sufficient information for a user to decide which
tools to use in which stage … End Stage Renal Disease and
Depression: A Systematic Review. … Javascript converts from one syntax to another
and inserts Boolean connectors in at the end of analysis
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
October 01, 2011 - Revised to clarify that “end of followup” results were through 12
months (page 17, line 15). … observational studies found acetaminophen associated
with modest increases in blood pressure or higher risk of renal … Hypertension is the second leading
cause of kidney failure or End Stage Renal
Disease in the United … Effects of NSAIDs on HTN and renal function are
reviewed starting on page 66, line 7.
Rosa L. … At the end of the treatment
period, absolute differences were statistically
significant as compared
-
effectivehealthcare-admin.ahrq.gov/products/mrsa-screening-2010/research-protocol
December 01, 2019 - Anticipated subgroups include patients at high-risk for MRSA, including those with end-stage renal disease … Key Informants
Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
November 01, 2019 - Matter Experts and Clinical
Informaticists Improved Clinical Accuracy and Usability of the Final CDS End … To that end, this AHRQ EPC methods project had two primary aims:
1. … Development of Tools and an Environment for Conducting End
User L3 and L4 Artifact Testing To Assess … In the software development lifecycle, this stage of testing is often referred to as “black
box” testing … implementing a
computerized clinical decision support system
for medication dosing for patients with renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - Intensive multimodality
therapy for patients
with stage 4a
metastatic
retinoblastoma. … risk solid
tumors
Safety/Efficacy
Study
12
4/1999-
9/2012
United States
FU: Annually
until end … Phase II
treatment
study
60 (ages 6 to
59 years)
9/1994 - End
date not
provided
United States … weight)
Systemic Lupus
Erythematosus Disease
Activity Index
Lupus serology (ANA, dsDNA,
C3, C4)
Renal … Supportive
care
intervention
150 (75 per
arm)
1/2004 – End
date not
reported
United States
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - Based on this input, our
overall assessment is that this intervention is in the lower end of
the … glucose levels in urine were
reported in some trials.
76
Additionally, long-term safety data on renal … Experts believe that the proposed mechanism of action of reducing blood glucose levels by
preventing renal … Lilly and Amylin mutually agree to end diabetes
alliance and transition exenatide responsibility to … Selected pharmaceuticals in
late stage U.S. and E.U. development or
registration.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mrsa-screening-2010_research-protocol.pdf
January 01, 2010 - Anticipated subgroups include patients at high-risk for MRSA, including those
with end-stage renal … Key Informants
Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users,
individuals are invited to serve as Key Informants and those who
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
October 19, 2016 - Thus my 1st several readings left me w/ a feeling that
it seems to almost "end before it begins." … sentences, legible
orders, medication list maintenance, some decision-
support successes (allergies, renal … No response needed
Peer Reviewer #5 Background I thought this set the stage nicely. … I assume that keeping them anonymous at this stage
is standard practice, but it would help to have a … It is AHRQ practice to keep them anonymous at
the draft stage.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
January 01, 2014 - • Was attrition <20% at the end of treatment? … One trial specified
that the researchers looked for toxicities of meditation to
hematologic, renal, … Mindfulness training and
stress reactivity in substance abuse: results from a randomized,
controlled stage … Change in women’s
diet and body mass following intensive intervention for early-stage
breast cancer … effects of
mindfulness-based stress reduction on psychosocial outcomes and
quality of life in early-stage
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - disease, thyroid disorders
5.4 Others: tumoral obstruction, fibrosing mediastinitis, chronic renal … Limited
data suggest that epoprostenol and bosentan may provide
a survival benefit; however, this end … At the full-
text screening stage, two independent reviewers read
each article to determine if it met … Of
these, 1,127 were excluded at the full-text screening
stage, leaving 197 articles (representing … – Consider studies of additional promising measures
such as end diastolic pulmonary regurgitation
-
effectivehealthcare-admin.ahrq.gov/products/coronary-artery-disease-testing/research-protocol
December 01, 2019 - Harms, risks and consequences of testing
Procedural harms, adverse events of testing (e.g., renal … , risks and consequences of testing (both initial and subsequent testing):
Harms of testing (renal … Thus, to set the stage for the review’s Key Questions, which are focused on clinical decisionmaking and … Key Informants
Key informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as key informants and those who
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
January 01, 2012 - also increases the risk of several types
of cancer including colorectal, endometrial, esophageal, renal … The phentermine plus topiramate combination is administered
daily as an oral medication.
3
In late-stage … Based on this input, our overall assessment is that this intervention is in the
higher end of the high-potential-impact … Based on this input, our overall assessment is that this intervention is in the lower end of the high
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - the study questions, the EPC consulted a panel of Key Informants who represent
subject experts and end-users … Therefore, in the end, study questions, design, methodological
approaches, and/or conclusions do not … Because of their role as end-users,
individuals with potential conflicts may be retained. … Open
Label|Primary Purpose: Treatment
NCT00878176 Sacral Neuromodulation Test With
Bilateral First Stage … Patients with Non-
obstructive Urinary Retention: A
Pilot Study
Urinary Retention Procedure: First stage
-
effectivehealthcare-admin.ahrq.gov/products/safety-vaccines/protocol
January 01, 2021 - transplantation: official publication of the European Dialysis and Transplant Association - European Renal … Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage … renal disease population unresponsive to primary vaccination series. … Renal failure. 2015;37(7):1080-8.
Zafack JG, De Serres G, Kiely M, et al. … Nervous system disorders
Pregnancy, puerperium and perinatal conditions
Psychiatric disorders
Renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
June 01, 2012 - contrast agent used
during the procedure to visualize the coronary arteries may
cause anaphylaxis, renal … During the topic refinement stage, we solicited input
from Key Informants, representing clinicians ( … At the full-text screening
stage, two independent reviewers read each article to
determine if it met … At the full-text
review stage, paired researchers independently reviewed
the articles and indicated … Of these, 1,662
articles were excluded at the full-text screening stage.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
January 01, 2013 - For example, in
patients with end-stage liver disease, the natural history of disease is so well known … We excluded CERs at the draft stage at the time of
the last search because draft reports have not been … As an example, the change in blood
pressure is assessed in patients with renal artery stenosis before … For example, there may be variability in the stage of disease presentation of
pathological features